Unity Biotechnology
VerifiedCreating therapeutics that prevent, halt, or reverse numerous diseases of aging.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$11m (Public information from May 2024)
Share price
$1.6 UBX
South San Francisco California (HQ)
No columns specified